Form 4 for ARBE Arbe Robotics Ltd.
Accepted 2026-09-11 17:00:02 ET · period of report 2026-09-03 · accession 0001213900-26-099321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-11 17:00 | 2026-09-03+ | ARBE | Arkind Noam | CTO, Dir | S - Sale | $0.7538 | -337.3K | 1.22M | -22% | -$254.3K |
| T | 2026-09-11 17:00 | 2026-09-09 | ARBE | Arkind Noam | CTO, Dir | A - Grant | $0.00 | +185.0K | 1.41M | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-03 | S | D | 35,800 | $0.6321 | 1,525,482 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2026. |
| 2 | Common | Ordinary Shares | 2026-09-04 | S | D | 22,700 | $0.6294 | 1,502,782 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2026. |
| 3 | Common | Ordinary Shares | 2026-09-08 | S | D | 278,800 | $0.7796 | 1,223,982 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2026. |
| 4 | Common | Restricted Shares | 2026-09-09 | A | A | 185,000 | $0.00 | 1,408,982 | D | — | — | (F1) The reported securities are restricted ordinary shares granted under the Company's equity incentive plan. The shares vest in full on April 1, 2027, subject to the reporting person's continued service through the vesting date, and are subject to forfeiture until vesting. The award was approved by the Board on April 22, 2026, subject to shareholder approval, and was approved by the Company's shareholders at the annual general meeting held on September9, 2026. |